---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-092761"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2023-12-04T23:59:59+00:00"
generated_at: "2026-06-07T18:42:19.663224+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma shareholders approve 80% authorized share reduction and equity plan at annual meeting

## Summary
- Four directors elected: Weisblum, Linsley, Muñoz, Pavell (1.45M-1.45M for each).
- Amended 2020 Omnibus Equity Incentive Plan approved (1.43M for, 97,553 against, 11,988 abstain).
- Authorized common shares reduced from 500M to 100M (1.52M for, 2,648 against, 10,000 abstain).
- Ratification of Salberg & Company as auditor approved (1.51M for, 189 against, 66,435 abstain).
- Vote on reincorporation to Nevada adjourned to December 11, 2023; results to be filed later.

## SEC filing metadata
- accession: 0001213900-23-092761
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2023-12-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390023092761/0001213900-23-092761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390023092761/ea189483-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-092761
- JSON: https://secwatch.observer/filing/0001213900-23-092761.json
- Plain text: https://secwatch.observer/filing/0001213900-23-092761.txt

## Key facts
- Shareholder Votes
  Silo Pharma, Inc. shareholders approved Election of four directors at the 2023-12-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-12-04
  source text: The result of the votes to elect the four directors was as follows: Directors For Withheld Broker Non-Votes Eric Weisblum 1,448,375 88,266 40,875 Wayne D. Linsley 1,406,716 129,925 40,875 Dr. Kevin Muñoz 1,422,577 114,064 40,875 Dr. Jeff Pavell 1,448,425 88,216 40,875
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390023092761/0001213900-23-092761-index.htm
- Shareholder Votes
  Silo Pharma, Inc. shareholders approved Amendment to Certificate of Incorporation to decrease authorized shares from 500,000,000 to 100,000,000 at the 2023-12-04 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-12-04
  source text: The result of the votes to approve the Share Decrease Proposal was as follows: For Against Abstain Broker Non-Vote 1,523,993 2,648 10,000 40,875
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390023092761/0001213900-23-092761-index.htm
- Shareholder Votes
  Silo Pharma, Inc. shareholders approved Ratification of appointment of Salberg & Company, P.A. as independent public accountant at the 2023-12-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-04
  source text: The result of the votes to approve Salberg & Company, P.A. was as follows: For Against Abstain 1,510,892 189 66,435
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390023092761/0001213900-23-092761-index.htm
- Shareholder Votes
  Silo Pharma, Inc. shareholders approved Approval of Amended and Restated 2020 Omnibus Equity Incentive Plan at the 2023-12-04 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-12-04
  source text: The result of the votes to approve the Amended 2020 Plan was as follows: For Against Abstain Broker Non-Vote 1,427,100 97,553 11,988 40,875
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390023092761/0001213900-23-092761-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.